Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cooling in Sclerotherapy
NCT04690803Phase 4Unknown
- Sponsor
- Cosmetic Laser Dermatology
- Start
- Jan 2020
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (2 arms), sponsored by Cosmetic Laser Dermatology. Primary endpoint: Effect of forced-air cooling on sclerotherapy efficacy at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT04690803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690803.